Luzuriaga K - Search Results

1

Luzuriaga K, Sullivan JL. Luzuriaga K, et al. N Engl J Med. 2010 May 27;362(21):1993-2000. doi: 10.1056/NEJMcp1001116. N Engl J Med. 2010. PMID: 20505178 Review. No abstract available.

2

A trial of three antiretroviral regimens in HIV-1-infected children.

Luzuriaga K, McManus M, Mofenson L, Britto P, Graham B, Sullivan JL; PACTG 356 Investigators. Luzuriaga K, et al. N Engl J Med. 2004 Jun 10;350(24):2471-80. doi: 10.1056/NEJMoa032706. N Engl J Med. 2004. PMID: 15190139 Free article. Clinical Trial.

3

Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis.

Clute SC, Watkin LB, Cornberg M, Naumov YN, Sullivan JL, Luzuriaga K, Welsh RM, Selin LK. Clute SC, et al. Among authors: luzuriaga k. J Clin Invest. 2005 Dec;115(12):3602-12. doi: 10.1172/JCI25078. Epub 2005 Nov 23. J Clin Invest. 2005. PMID: 16308574 Free PMC article.

4

On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis.

Hadinoto V, Shapiro M, Greenough TC, Sullivan JL, Luzuriaga K, Thorley-Lawson DA. Hadinoto V, et al. Among authors: luzuriaga k. Blood. 2008 Feb 1;111(3):1420-7. doi: 10.1182/blood-2007-06-093278. Epub 2007 Nov 8. Blood. 2008. PMID: 17991806 Free PMC article.

5

Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection.

Luzuriaga K, Bryson Y, Krogstad P, Robinson J, Stechenberg B, Lamson M, Cort S, Sullivan JL. Luzuriaga K, et al. N Engl J Med. 1997 May 8;336(19):1343-9. doi: 10.1056/NEJM199705083361902. N Engl J Med. 1997. PMID: 9134874 Free article. Clinical Trial.

6

Phenotypic and functional heterogeneity of EBV epitope-specific CD8+ T cells.

Catalina MD, Sullivan JL, Brody RM, Luzuriaga K. Catalina MD, et al. Among authors: luzuriaga k. J Immunol. 2002 Apr 15;168(8):4184-91. doi: 10.4049/jimmunol.168.8.4184. J Immunol. 2002. PMID: 11937579

7

Pediatric HIV-1 infection: advances and remaining challenges.

Luzuriaga K, Sullivan JL. Luzuriaga K, et al. AIDS Rev. 2002 Jan-Mar;4(1):21-6. AIDS Rev. 2002. PMID: 11998780 Review.

8

Differential kinetics and specificity of EBV-specific CD4+ and CD8+ T cells during primary infection.

Precopio ML, Sullivan JL, Willard C, Somasundaran M, Luzuriaga K. Precopio ML, et al. Among authors: luzuriaga k. J Immunol. 2003 Mar 1;170(5):2590-8. doi: 10.4049/jimmunol.170.5.2590. J Immunol. 2003. PMID: 12594286

9

Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells.

Souza TA, Stollar BD, Sullivan JL, Luzuriaga K, Thorley-Lawson DA. Souza TA, et al. Among authors: luzuriaga k. Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18093-8. doi: 10.1073/pnas.0509311102. Epub 2005 Dec 5. Proc Natl Acad Sci U S A. 2005. PMID: 16330748 Free PMC article.

10

Vaccines to prevent transmission of HIV-1 via breastmilk: scientific and logistical priorities.

Luzuriaga K, Newell ML, Dabis F, Excler JL, Sullivan JL. Luzuriaga K, et al. Lancet. 2006 Aug 5;368(9534):511-21. doi: 10.1016/S0140-6736(06)69159-9. Lancet. 2006. PMID: 16890838 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

183 results

Search Page